🇺🇸 FDA
Patent

US 12171785

Pluripotent cells derived from bone marrow and methods for isolation

granted A61KA61K2035/124A61K2239/31

Quick answer

US patent 12171785 (Pluripotent cells derived from bone marrow and methods for isolation) held by Regents of the University of Minnesota expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2035/124, A61K2239/31, A61K35/28, A61K40/10